A
Alaunos Therapeutics, Inc. (TCRT)
NCM – Real Time Price. Currency in USD
2.08
+0.01 (0.48%)
At close: Jun 26, 2026, 4:00 PM EDT
2.41
+0.33 (15.87%)
After-hours: Jun 26, 2026, 7:38 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
2.08
+0.01 (0.48%)
At close: Jun 26, 2026, 4:00 PM EDT
2.41
+0.33 (15.87%)
After-hours: Jun 26, 2026, 7:38 PM EDT
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.
| Name | Position |
|---|---|
| Mr. Ferdinand Groenewald | Vice President of Finance & Corporate Secretary |
| Mr. Holger Weis CPA | Chairman of the Board & CEO |
| Date | Type | Document |
|---|---|---|
| 2026-05-26 | 8-K | tcrt-20260526.htm |
| 2026-05-18 | 8-K | tcrt-20260302.htm |
| 2026-05-15 | 10-Q | tcrt-20260331.htm |
| 2026-04-30 | 10-K/A | tcrt-20251231.htm |
| 2026-04-15 | 8-K | tcrt-20260409.htm |
| 2026-03-31 | 10-K | tcrt-20251231.htm |
| 2026-03-02 | 8-K | tcrt-20260302.htm |
| 2026-01-08 | 8-K | tcrt-20260108.htm |
| 2025-12-23 | 8-K | tcrt-20251217.htm |
| 2025-11-14 | 10-Q | tcrt-20250930.htm |